ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. (CLPT) Stock Overview
Explore ClearPoint Neuro, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
321M
P/E Ratio
-13.25
EPS (TTM)
$-0.83
ROE
-1.14%
CLPT Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of ClearPoint Neuro, Inc. (CLPT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 41.74, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $19.97.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -13.25 and a market capitalization of 321M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.